ID   Akata-eGFP-EBV
AC   CVCL_VN88
DR   JCRB; JCRB1764
DR   Wikidata; Q93324020
RX   PubMed=11562531;
CC   Population: Japanese.
CC   Virology: EBV-negative clone re-infected with a recombinant EBV in which eGFP was integrated in the BXLF1 gene.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0148 ! Akata
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
RX   PubMed=11562531; DOI=10.1099/0022-1317-82-10-2373;
RA   Maruo S., Yang L., Takada K.;
RT   "Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the
RT   infection of human epithelial cells.";
RL   J. Gen. Virol. 82:2373-2383(2001).
//